Ameriprise Financial Inc Durect Corp Transaction History

Ameriprise Financial Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.9 - $1.31 $10,980 - $15,982	-12,200 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.61 $1,936 - $2,576	-1,600 Reduced 11.59%	12,200 $16,000
Q2 2021 Aug 16, 2021	SELL	$1.6 - $2.02 $652 - $824	-408 Reduced 2.87%	13,800 $22,000
Q1 2021 May 17, 2021	BUY	$1.86 - $2.87 $2,418 - $3,731	1,300 Added 10.07%	14,208 $28,000
Q4 2020 Feb 12, 2021	SELL	$1.65 - $2.43 $6,435 - $9,477	-3,900 Reduced 23.2%	12,908 $27,000
Q1 2020 May 15, 2020	SELL	$0.97 - $2.85 $96,226 - $282,728	-99,203 Reduced 85.51%	16,808 $26,000
Q4 2019 Feb 14, 2020	SELL	$1.69 - $3.8 $2,366 - $5,320	-1,400 Reduced 1.19%	116,011 $446,000
Q3 2019 Nov 14, 2019	SELL	$0.61 - $2.21 $2,379 - $8,619	-3,900 Reduced 3.21%	117,411 $216,000
Q2 2019 Aug 14, 2019	SELL	$0.51 - $0.86 $9,140 - $15,413	-17,923 Reduced 12.87%	121,311 $79,000
Q1 2019 May 15, 2019	BUY	$0.51 - $0.82 $867 - $1,394	1,700 Added 1.24%	139,234 $87,000
Q4 2018 Feb 14, 2019	SELL	$0.48 - $1.1 $31,797 - $72,869	-66,245 Reduced 32.51%	137,534 $66,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $819 - $1,306	-773 Reduced 0.38%	203,779 $224,000
Q2 2018 Aug 14, 2018	BUY	$1.56 - $2.51 $12,246 - $19,703	7,850 Added 3.99%	204,552 $319,000
Q1 2018 May 15, 2018	BUY	$0.91 - $2.24 $1,536 - $3,781	1,688 Added 0.87%	196,702 $421,000
Q4 2017 Feb 12, 2018	SELL	$0.78 - $2.1 $5,271 - $14,191	-6,758 Reduced 3.35%	195,014 $180,000
Q3 2017 Nov 07, 2017	BUY	$1.55 - $1.82 $312,746 - $367,225	201,772	201,772 $357,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $223M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.